Alaunos Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Fort Lauderdale, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Alaunos Therapeutics, Inc. has filed 1,289 SEC EDGAR filings since 13 Feb 2001

SEC filing history

Showing 551-575 of 1,000 matching filings.

Per page
25
Current page
23
4

FORM 4

Filing date
30 Jun 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
15 Jun 2017
Reporting date
14 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2017
Reporting date
12 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2017
Reporting date
12 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2017
Reporting date
12 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2017
Reporting date
12 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jun 2017
Reporting date
01 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

8-K

Filing date
05 Jun 2017
Reporting date
05 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Jun 2017
Reporting date
31 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-79364

SC 13G

Filing date
22 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-201826

424B5

Filing date
12 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
12 May 2017
Reporting date
11 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 May 2017
Reporting date
05 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 May 2017
Reporting date
28 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
02 May 2017
Reporting date
02 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

8-K

Filing date
01 May 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33038

DEFA14A

Filing date
28 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33038

DEF 14A

Filing date
28 Apr 2017
Reporting date
14 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Mar 2017
Reporting date
31 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
27 Mar 2017
Reporting date
27 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Mar 2017
Reporting date
28 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
16 Feb 2017
Reporting date
16 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .